ImageneBio, Inc. (IMA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for ImageneBio, Inc. (IMA).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $15.75

Daily Change: -$0.74 / 4.70%

Daily Range: $15.60 - $16.50

Market Cap: $176,111,776

Daily Volume: 18,402

Performance Metrics

1 Week: 3.01%

1 Month: -4.20%

3 Months: 17.19%

6 Months: -7.57%

1 Year: -20.45%

YTD: -19.97%

Company Details

Employees: 10

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Selected stocks

Globus Maritime Limited (GLBS)

Imperial Petroleum Inc. - 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares (IMPPP)

Icon Energy Corp. (ICON)